Intubation of Obese Patients in the Operating Room With or Without Bag-Mask Ventilation

NCT ID: NCT05930678

Last Updated: 2025-07-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

725 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-12

Study Completion Date

2025-07-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to answer a daily question in the operating room: what is the safest technique for intubation of severe/morbid obese patients (BMI 35 or more). There is a great heterogeneity of practices on the subject, so the principle is to determine a common practice to facilitate the management of these patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Anesthesia consultation or pre-anesthesia visit:

* screening for inclusion and non-inclusion criteria
* patient information
* collection of consent
* inclusion

D0 (day of inclusion):

* before general anesthesia : collection of epidemiological data (history + clinical examinations) + randomization (Arm A/Not Vent : intubation without ventilation or Arm B/Vent : intubation with ventilation)
* general anesthesia : intubation according to randomization arm + collection primary endpoint + conduct of the intubation procedure + morbidity of the intubation procedure
* after general anesthesia : collection of secondary endpoints + conduct of the intubation procedure + morbidity of the intubation procedure + intraoperative respiratory morbidity
* post-interventional care room : collection of clinical parameters in the ICU : postoperative morbidity + study discharge (hospital discharge)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Morbid Obesity Ventilation Therapy; Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Morbidly obese patients (BMI greater than or equal to 35).
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Without ventilation

No ventilation sequence during the intubation period and without face mask ventilation during the apnea period

Group Type ACTIVE_COMPARATOR

No ventilation with face mask

Intervention Type PROCEDURE

During the period of apnea (in general anesthesia), the patient did not help with face mask

With ventilation

Sequence "with ventilation" during the apnea period with face mask ventilation

Group Type EXPERIMENTAL

Ventilation with face mask

Intervention Type PROCEDURE

During the pperiod of apnea (in general anesthesia), the patient did help with face mask

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ventilation with face mask

During the pperiod of apnea (in general anesthesia), the patient did help with face mask

Intervention Type PROCEDURE

No ventilation with face mask

During the period of apnea (in general anesthesia), the patient did not help with face mask

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patient requiring general anesthesia with intubation for surgery or scheduled endoscopic procedures
* age \> 18 years
* with a BMI superior or equal to 35kg.m-²
* patient having signed an informed consent


* ambient air saturation \<90%
* urgent surgery \< 24 hours
* cardio-thoracic surgery
* mask ventilation not possible (e.g. ATCD, cervical irradiation, fixed mandible)
* formal contraindication to mask ventilation (e.g. occlusive syndrome, non fasting patient, symptomatic gastroesophageal reflux untreated or persistent under treatment)
* wish of the operator for high flow oxygen preoxygenation
* wish of an intubation without curare by the operator
* pregnant or breast-feeding women
* protected adults (guardianship, curatorship or safeguard of justice)
* participation in another randomized clinical research study concerning preoxygenation and relevant to the primary endpoint
* absence of affiliation to the French social security system
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nantes University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mickael VOURC'H, PhD

Role: PRINCIPAL_INVESTIGATOR

Nantes University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Nantes

Nantes, Loire Atlantique, France

Site Status

CHU Angers

Angers, , France

Site Status

CHRU Brest

Brest, , France

Site Status

CHU de Dijon

Dijon, , France

Site Status

CHD Vendée

La Roche-sur-Yon, , France

Site Status

CHRU de Lille - Hôpital Claude Huriez

Lille, , France

Site Status

HCL - Hôpital Edouard Herriot

Lyon, , France

Site Status

CHU de Nantes - site Laennec

Nantes, , France

Site Status

CHU de Rennes

Rennes, , France

Site Status

CH de Saint-Nazaire

Saint-Nazaire, , France

Site Status

Clinique Mutualiste de l'Estuaire

Saint-Nazaire, , France

Site Status

CHU Toulouse

Toulouse, , France

Site Status

CH de Valenciennes

Valenciennes, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RC22_0359

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.